Suzetrigine-evoked analgesia is potentiated by Nav1.7 null-related opioid mechanisms.
Eva Villalba Riquelme, Olena Didenko, Sam Gossage, Jorg Isensee, Tim B. Hucho, John N. Wood
The paper investigates how Nav1.7 loss enhances opioid signaling and analgesia, showing that suzetrigine-evoked analgesia is potentiated by RGS antagonists and low-dose morphine in inflammatory pain models.
bioRxiv · Oct 12, 2026 · PreprintNeuroscience